Novo Nordisk India revises pricing to make vital therapies more affordable for patients managing diabetes and obesity ...

A new research study provides real-world evidence that deprescribing glucose-lowering medications is both feasible and safe ...

ST. LOUIS, March 31, 2026 /PRNewswire/ -- A new research study from the American College of Lifestyle Medicine provides real-world evidence that deprescribing glucose--lowering medications is both ...

Novo Nordisk India has cut the prices of its diabetes and weight loss medicine brands Ozempic and Wegovy (GLP-1 receptor ...

The Drug Controller General of India (DCGI) has intensified regulatory oversight against the unauthorized sale and promotion ...

Eye doctors say GLP-1 drugs for diabetes and weight loss may pose rare vision risks, recommending regular checkups.

The Government of India on Thursday released official guidance on the use, risks, and regulation of GLP-1 (glucagon-like ...

CLEVELAND, Ohio — More people are taking GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight and control Type 2 ...

The Government of India has tightened regulation of GLP-1 drugs used for diabetes and weight loss, restricting prescriptions ...

Health Ministry warns against misuse of GLP-1 drugs for diabetes and weight loss, stresses strict medical supervision due to ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

For millions of people living with Type 2 diabetes, managing blood sugar is a daily balancing act which involves medication, meals, and lifestyle choices. While doctors often adjust drug dosages and ...